An answer to "anticoagulant treatment of cancer-associated venous thromboembolism: Interpreting real-world data with caution".

Streiff, Michael B; Milentijevic, Dejan; McCrae, Keith; Yannicelli, Daniel; Lejeune, Dominique; Nelson, Winnie W; Laliberté, François; Crivera, Concetta; Lefebvre, Patrick; Schein, Jeff; Khorana, Alok A

Streiff, Michael B; Milentijevic, Dejan; McCrae, Keith; Yannicelli, Daniel; Lejeune, Dominique; Nelson, Winnie W; Laliberté, François; Crivera, Concetta; Lefebvre, Patrick; Schein, Jeff; Khorana, Alok A.

Afiliação

Streiff MB; Johns Hopkins School of Medicine, Baltimore, Maryland.
Milentijevic D; Janssen Scientific Affairs, LLC, Raritan, New Jersey.
McCrae K; Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio.
Yannicelli D; Janssen Pharmaceuticals, Inc, Raritan, New Jersey.
Lejeune D; Groupe d'analyse Ltée, Montréal, Québec, Canada.
Nelson WW; Janssen Scientific Affairs, LLC, Raritan, New Jersey.
Laliberté F; Groupe d'analyse Ltée, Montréal, Québec, Canada.
Crivera C; Janssen Scientific Affairs, LLC, Raritan, New Jersey.
Lefebvre P; Groupe d'analyse Ltée, Montréal, Québec, Canada.
Schein J; Janssen Scientific Affairs, LLC, Raritan, New Jersey.
Khorana AA; Cleveland Clinic - Taussig Cancer Center, Cleveland, Ohio.

Am J Hematol ; 93(9): E225-E227, 2018 09.

Article em En | MEDLINE | ID: mdl-29905381

Assuntos

Neoplasias; Tromboembolia Venosa; Anticoagulantes; Heparina de Baixo Peso Molecular; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google